Skip to main content
European Commission logo
Live, work, travel in the EU
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Multi-platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19

DOI
10.1093/jalm/jfaa139 
Detection Principle
ImmunoAssay-Antibody
Target
IgM and IgG
Testing Method Category
Other Immuno assay
Testing Method
Diazyme, Roche, and Abbott SARS-CoV-2 serology assays
Testing Method - Additional Info
comparison of the performance of the Diazyme, Roche, and Abbott SARS-CoV-2 serology assays
Reported Performance
sensitivity ?7-day: Diazyme IgM: 58.1%; Diazyme IgG: 67.4%; Diazyme IgM/IgG panel: 69.8%; Roche total Ig: 67.4%; Abbott IgG: 67.4%. 8–14-day: Diazyme IgM: 93.5%; Diazyme IgG: 96.8%; Diazyme IgM/IgG panel: 96.8%; Roche total Ig: 100.0%; Abbott IgG: 100.0%. ?15-day: Diazyme IgM: 92.0%; Diazyme IgG: 96.0%; Roche total Ig: 96%; Diazyme IgM/IgG panel: 100%; Abbott IgG assay: 100%.
Sample Size
66 positive, 179 negative
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements